Nouveaux membres

SERB

We are very pleased to welcome SERB as a member of the French-Norwegian Chamber of Commerce.

With a turnover of 80 millions euros in 2019, SERB is an independent pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Directly established in Belgium, France, Uk, germany, Poland and Luxembourg, the group is present in over 60 countries through a large network of over 50+ experienced distributors. Following strategic acquisitions from Tier 1 pharmaceutical companies, SERB has succeeded in building a consistent drugs portfolio focused on niiche specialty pharmaceuticals. The group has consolidated a global leading position in therapeutic areas such as Critical & Emergency Care, Diagnostic agents, Endocrinology and Neurology.

 

For more information about SERB, please visit their website.

Plus d'actualités

Prochain événement

Partager cette page Partager sur FacebookPartager sur TwitterPartager sur Linkedin

Fenêtre pop-up - Informations

Fermer

Abonnez-vous à notre Newsletter !